Researcher.Life Logo

Drug Metabolism and Disposition : Impact Factor & More

eISSN: 1521-009XpISSN: 0090-9556

Aims and Scope of Drug Metabolism and Disposition

Drug Metabolism and Disposition is a peer-reviewed scientific journal covering the fields of pharmacology and toxicology. It was established in 1973 and is published monthly by the American Society for Pharmacology and Experimental Therapeutics. The journal publishes articles on in vitro and in vivo studies of the metabolism, transport, and disposition of drugs and environmental chemicals, including the expression of drug-metabolizing enzymes and their regulation. As of 2011, the editor-in-chief is Edward T. Morgan (Emory University). Less

Key Metrics

CiteScore
7
Eigenfactor
0.005 - 0.01
H-Index
189
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
1.13
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Drug Metabolism and Disposition

Drug Metabolism and Disposition Journal Specifications

Overview
Publisher AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1973
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Drug Metabolism and Disposition ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Metabolism and Disposition

Virtual special section: Novel animal models.
  • 10 Jun 2026
  • Drug metabolism and disposition: the biological fate of chemicals
Role of organic anion transporting polypeptides in pancreatic statin disposition and islet cell function in mice.
  • 1 Jun 2026
  • Drug metabolism and disposition: the biological fate of chemicals
Age (juvenile to aged) and sex effects on in vitro CYP2A6 enzyme activity in African green monkeys using nicotine and coumarin.
  • 30 May 2026
  • Drug metabolism and disposition: the biological fate of chemicals
Cytochrome P450-mediated metabolism of K31, a Ko143-derived ATP-binding cassette subfamily G member 2 inhibitor.
  • 20 May 2026
  • Drug metabolism and disposition: the biological fate of chemicals
Mechanistic insights into edoxaban's nonlinear pharmacokinetics and quinidine interaction via P-glycoprotein using physiologically based pharmacokinetic modeling.
  • 20 May 2026
  • Drug metabolism and disposition: the biological fate of chemicals
Virtual special section: Sex and hormonal influences on drug metabolism and disposition, and related studies.
  • 16 May 2026
  • Drug metabolism and disposition: the biological fate of chemicals
Virtual special section: Novel animal models.
  • 10 Jun 2026
  • Drug metabolism and disposition: the biological fate of chemicals
Role of organic anion transporting polypeptides in pancreatic statin disposition and islet cell function in mice.
  • 1 Jun 2026
  • Drug metabolism and disposition: the biological fate of chemicals
Age (juvenile to aged) and sex effects on in vitro CYP2A6 enzyme activity in African green monkeys using nicotine and coumarin.
  • 30 May 2026
  • Drug metabolism and disposition: the biological fate of chemicals
Cytochrome P450-mediated metabolism of K31, a Ko143-derived ATP-binding cassette subfamily G member 2 inhibitor.
  • 20 May 2026
  • Drug metabolism and disposition: the biological fate of chemicals
Mechanistic insights into edoxaban's nonlinear pharmacokinetics and quinidine interaction via P-glycoprotein using physiologically based pharmacokinetic modeling.
  • 20 May 2026
  • Drug metabolism and disposition: the biological fate of chemicals
Virtual special section: Sex and hormonal influences on drug metabolism and disposition, and related studies.
  • 16 May 2026
  • Drug metabolism and disposition: the biological fate of chemicals

FAQs on Drug Metabolism and Disposition